RCUS
RCUS
US03969F1093
Arcus Biosciences, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.11B EUR
3.92B EUR
2.71B EUR
2.99B EUR
Enterprise Value
2.57B EUR
3.88B EUR
2.62B EUR
2.88B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.47x
--
--
--
Price to Sales
26.57x
33.47x
11.49x
13.63x
Price to Book
6.68x
8.44x
5.17x
4.73x
EV/Revenue
21.97x
33.16x
11.11x
13.13x
EV/EBITDA
-5.4x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-8.71%
-12.13%
-18.04%
-11.76%
ende